This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Johnson & Johnson

Drug Names(s): Flubendazole

Description: Flubendazole is a benzimidazole anti-parasitic agent with broad spectrum activity against intestinal parasites.

Deal Structure: Flubendazole was originally discovered and developed by Janssen.

JNJ and DNDi
Janssen entered into a non-exclusive, royalty-free preclinical data sharing agreement with the Drugs for Neglected Diseases initiative (DNDi) for the preclinical research of a reformulated form of flubendazole.

Partners: Drugs for Neglected Diseases initiative

Flubendazole News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug